Antimicrobial resistance (AMR) is one of the most serious global public health threats in this century, according to the World Health Organization, attributing to 1.27 million deaths annually with the highest burden in low- and middle-income countries.

A new study funded by the Army Research Office through the ICB investigates the competitive consequences when organisms adopt a non-genomic metabolism—trading cards in the game of life—with ramifications for a species’ evolution and ecology.

Inspirational project leader of two ICB projects and distinguished professor of Materials and Chemistry & Biochemistry at UCSB, Craig Hawker has been elected to the National Academy of Sciences (NAS) and takes his place among the academy’s 3,029 national and international members.

ICB Project Leader Michael Mahan and a collaborative team have developed a new test that diagnoses sepsis—the body’s life-threatening extreme response to infection—soon after infection, potentially increasing patient survival rates in a condition that kills more than 250 thousand Americans annually.

New pioneering research conducted by scientists from the lab of Mikhail Shapiro, ICB project leader and Caltech professor of Chemical Engineering, has demonstrated a new mechanism for reducing cancerous tumor growth and overcomes the limitations of most current microbial cancer therapies with the use of genetically engineered therapeutic bacteria that are remotely controlled by thermal focused ultrasound (FUS).